3-十一烷基-1,2-苯二酚合成路线 （共 9 条）
反应条件
hydrogenchloride in 1,4-dioxane 10 h; Heating;
参考文献
Miyakoshi, Tetsuo; Togashi, Hiroyasu
Synthesis, 1990 , # 5 p. 407 - 410
反应条件
1: H2, aq. H2SO4 / Pd-C / ethyl acetate 2: Py*HCl / Heating View Scheme
参考文献
Kurtz,A.P.; Dawson,C.R.
Journal of Medicinal Chemistry, 1971 , vol. 14, p. 729 - 732
反应条件
1: KOH 3: H2, aq. H2SO4 / Pd-C / ethyl acetate 4: Py*HCl / Heating View Scheme
参考文献
Kurtz,A.P.; Dawson,C.R.
Journal of Medicinal Chemistry, 1971 , vol. 14, p. 729 - 732
反应条件
2: H2, aq. H2SO4 / Pd-C / ethyl acetate 3: Py*HCl / Heating View Scheme
参考文献
Kurtz,A.P.; Dawson,C.R.
Journal of Medicinal Chemistry, 1971 , vol. 14, p. 729 - 732
反应条件
1: 81 percent / LiClO4 / 45 °C / electrolysis at 0.06 A, 10 V 2: 94 percent / H2 / 5percent Pd/C / ethyl acetate / 6 h / 760 Torr / Ambient temperature 3: 75 percent / aq. 1 M HCl / dioxane / 10 h / Heating View Scheme
参考文献
Miyakoshi, Tetsuo; Togashi, Hiroyasu
Synthesis, 1990 , # 5 p. 407 - 410
反应条件
1: 69 percent / MnO2 / benzene / 36 h / Ambient temperature 2: 81 percent / LiClO4 / 45 °C / electrolysis at 0.06 A, 10 V 3: 94 percent / H2 / 5percent Pd/C / ethyl acetate / 6 h / 760 Torr / Ambient temperature 4: 75 percent / aq. 1 M HCl / dioxane / 10 h / Heating View Scheme
参考文献
Miyakoshi, Tetsuo; Togashi, Hiroyasu
Synthesis, 1990 , # 5 p. 407 - 410
反应条件
1: 94 percent / H2 / 5percent Pd/C / ethyl acetate / 6 h / 760 Torr / Ambient temperature 2: 75 percent / aq. 1 M HCl / dioxane / 10 h / Heating View Scheme
参考文献
Miyakoshi, Tetsuo; Togashi, Hiroyasu
Synthesis, 1990 , # 5 p. 407 - 410
反应条件
1: Mg / tetrahydrofuran / 3 h / Ambient temperature 2: H2, cc. sulfuric acid / 5percent Pd-C / ethyl acetate View Scheme
参考文献
Itokawa; Totsuka; Nakahara; Maezuru; Takeya; Kondo; Inamatsu; Morita
Chemical and Pharmaceutical Bulletin, 1989 , vol. 37, # 6 p. 1619 - 1621
反应条件
1: Mg / tetrahydrofuran / 3 h / Ambient temperature 2: H2, cc. sulfuric acid / 5percent Pd-C / ethyl acetate View Scheme
参考文献
Itokawa; Totsuka; Nakahara; Maezuru; Takeya; Kondo; Inamatsu; Morita
Chemical and Pharmaceutical Bulletin, 1989 , vol. 37, # 6 p. 1619 - 1621
